Intravenous Infusions is trading at GHS 0.61, down 3.17%, with no verified company-specific announcement explaining the decline. - The company website lists an upcoming October 23, 2026 annual general meeting; no evidence links it to the price move. - Available reports conflict on October 19 market direction and the stock’s quoted price, leaving broader-market causation unclear. - The supplied price history shows a volatile run-up before the decline but does not establish a cause.